This study aims to evaluate the safety of inactivated COVID-19 vaccine among adult people living with HIV (PLWH). In total, 259 PLWH who received at least one dose of inactivated COVID-19 vaccine were enrolled, and post-vaccination adverse events (AEs) were evaluated seven days following each vaccination dose. The overall AE frequency was 22.8% after dose one, which was higher than after dose two (10.2%) ( P < 0.001). No severe side event or vaccine safety concern was observed. Our finding was essential in reducing vaccine hesitancy among PLWH.
All Keywords
【저자키워드】 COVID-19, Inactivated vaccine, adverse event, People living with HIV(PLWH), 【초록키워드】 Vaccine, COVID-19 vaccine, vaccination, Vaccine hesitancy, PLWH, inactivated, Frequency, dose, Seven, enrolled, evaluate, evaluated, reducing, with HIV, AEs, 【제목키워드】 COVID-19 vaccine, inactivated, Adverse, event,
【저자키워드】 COVID-19, Inactivated vaccine, adverse event, People living with HIV(PLWH), 【초록키워드】 Vaccine, COVID-19 vaccine, vaccination, Vaccine hesitancy, PLWH, inactivated, Frequency, dose, Seven, enrolled, evaluate, evaluated, reducing, with HIV, AEs, 【제목키워드】 COVID-19 vaccine, inactivated, Adverse, event,